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Background Epidemiological data on serum lipoprotein(a) (Lp(a)l, a presumably strong risk factor for coronary artery
disease in White populations, has mostly been derived, in Black populations, from small samples. This study compares
the distribution and the determinants of serum Lp(a) in Blacks and in Whites using large representative samples and the
same methods in both populations.
Methods The distribution and the correlates of serum Lp(a) were investigated in population-based samples of 701
Blacks in the Seychelles and 634 Whites in Switzerland, aged 25-64 years. Serum Lp(a) was quantified using a com-
mercial immunoradiometric assay.
Results The distribution of serum Lp(a) was similarly skewed in both ethnic groups, but median Lp(a) concentration
was about twofold higher in Blacks (210 mg/l) compared to Whites (100 mg/l). The proportions of individuals with
elevated serum Lp(a) O300 mg/l) was about 50% higher in Blacks (37.5%) than in Whites (25.2%). In both ethnic
groups, serum Lp(a) was found to correlate with total cholesterol, LDL-cholesterol and apoprotein B but not with HDL-
cholesterol, alcohol intake, smoking, and body mass index. The variance in serum Lp(a) concentration explained by
any combination of these factors was smaller than 5.3% in the two populations.
Conclusions The measured factors did not explain the higher levels of serum Lp(a) found in Blacks compared to
Whites. These findings are consistent with the hypothesis that genetic factors account for much of the variation of
serum Lp(a) in both populations.
Lipoprotein(a) (Lp(a)) is a cholesterol-rich lipoprotein
found in human serum that resembles low-density
lipoprotein (LDL) but contains in addition apolipo-
protein(a) (apo(a)) which has close structural
homology with plasminogen.12 A single gene appears
to determine a size polymorphism of apo(a) which
relates to serum Lp(a) concentration and family
studies indicate that more than 90% of the inter-
individual variation in serum Lp(a) is determined by
this gene encoding apo(a).3-4 Serum Lp(a) concentra-
tions are fairly constant throughout an individual's life
but vary between individuals over a wide range (from
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<0.1 to >4000 mg/l) with a highly skewed distribu-
tion, at least in White (Caucasian) populations.2'5"7
Although its function is not established, Lp(a) has
thrombotic and atherogenic properties.8 Indeed,
serum Lp(a) is currently gaining much attention as a
quantitative, genetically controlled, independent risk
factor for prediction of coronary artery disease in
Caucasian populations.9"13 However, the role of serum
Lp(a) as a risk factor for coronary artery disease in
Blacks is controversial.14'16
Distribution of serum Lp(a) has been repeatedly
examined in White populations2-3"7 although only a
few studies included population-based data17 and not
all of them provided the appropriate distribution
measures, such as medians and percentiles, needed for
comparison between populations. In contrast, few
studies have examined serum Lp(a) distribution in
Blacks and most of them included small samples and
were not designed to be representative of the whole
population. When comparing serum Lp(a) distribution
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in Blacks and in Whites, it has been reported that
Lp(a) was markedly more Gaussian in Blacks than in
Whites,218"21 a finding that is not supported by our
data.
This report provides data on serum Lp(a) distribu-
tion in the Black population of the Seychelles and
in the White population of Switzerland. Large
population-based samples and the same study designs
and laboratory methods were used for both popula-
tions, so that valid comparisons can be drawn between
these two ethnically different populations. The rela-
tion of serum Lp(a) to other factors was also examined
in the two populations.
METHODS
Study Populations
The Seychelles Islands are located in the Indian Ocean,
approximately 1800 km east of Kenya and 1800 km
north of Mauritius, and are now considered a middle-
level income country with an annual gross national
product per capita of >US$350O. The population of
the Seychelles consists of a mixed rural-urban popula-
tion. The Seychelles had no indigenous population
until 1770 when French settlers arrived, joined later by
a large number of people from the eastern coast of
Africa and a small number of English, Indians and
Chinese.22
In the Seychelles, cardiovascular risk factors in the
population were determined in 1989 within the frame-
work of the Seychelles Cardiovascular Disease Study.23
The population screened was the population of Mahe
Island, which accounts for approximately 90% of the
total population of the Seychelles (66 370). A random
sample of the population aged 25-64 years, stratified
by sex and age, was drawn; 1081 (86.4"%) individuals
took part in the survey out of 1251 eligible. This study
included only individuals who were of African descent
(730) based on external anthropomorphic features as
assessed by the same investigator (PB) throughout the
whole survey. Serum Lp(a) could not be determined
in 29 individuals due to shortage of serum, hence
data from 701 individuals were analysed. Detailed
sampling procedures, laboratory methods, and socio-
demographic data have been reported previously.24
In Switzerland, a similar population survey was car-
ried out in 1988-1989 within the framework of the
WHO MONICA project. The sampling procedure has
been previously reported in detail.25 Briefly, a two-
stage sampling procedure was used to obtain a
representative sample of the adult population. A par-
ticipation rate of 65% was obtained among the 3210
individuals eligible to take part in the survey in the
cantons of Vaud and Fribourg. One hundred serum
samples were then randomly selected to determine
serum Lp(a) in each group stratified for sex- and
10-year age group. This study was further restricted to
Swiss nationals and only data from people aged 25-64
years were used in the comparisons with the Seychelles.
Hence, data from 634 individuals were analysed.
Laboratory Methods
Frozen fasting (Seychelles) and non-fasting (Switzer-
land) sera were analysed in Switzerland less than 18
months after blood collection. Serum Lp(a) was
measured in one single laboratory using a commercial
solid phase two-site immunoradiometric assay (Apo(a)
RIA, Pharmacia, Uppsala, Sweden) similar to the one
reported by Albers et al.26 The assay was sensitive in
the concentration range 0.2 U/l to ^8000 U/l which
corresponds approximately to mass units 0.1 mg/1 to
^5600 mg/l. The day to day variation coefficient was
less than 6°Io. No measurable cross-reaction occurred
with serum plasminogen or apoprotein B (apoB).
Serum total cholesterol was determined enzymatically
(Roche, Basel, Switzerland). Serum high density
lipoprotein (HDL) cholesterol was similarly quantified
after precipitation of the apoB-containing lipoproteins
with phosphotungstate and magnesium chloride
(Roche). Serum apoproteins A-I (apoA) and apoB
were quantified by immunoturbidimetry (Turbitimer™
System, Behring, Marburg, Germany). Serum low
density lipoprotein (LDL) cholesterol was calculated
(Seychelles) with the Friedewald formula and
measured (Switzerland) after precipitation with an
amphiphilic polymer (Bio-Merieux, Lyons, France).
Anthropometric and Lifestyle Variables
Blood pressure, weight and height were measured ac-
cording to the WHO MONICA study protocol27 and
data on smoking were obtained from a questionnaire.
Body mass index was used as an index of obesity
(weight (kg)/height (m)2). Alcohol intake was calcu-
lated as grams of pure alcohol per day based on a
detailed questionnaire on alcohol habits (Seychelles)
and dichotomized (consumption of alcohol versus no
consumption) according to the reported consumption
on the previous day (Switzerland).
Statistical A nalysis
Normally distributed variables and categorical
variables were compared using t- and x2 tests, respec-
tively. Because serum Lp(a) was not normally
distributed, the Wilcoxon rank-sum test was used to
compare medians between sex and race groups. The
Mantel-Haenszel test was used to evaluate the associa-
tion between ethnicity and an elevated level of serum
22 INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
Lp(a). Multiple logistic regression was used to in-
vestigate the association between ethnicity and an
elevated serum Lp(a) after adjustment for selected
variables. The univariate relation of serum Lp(a) to
other variables was examined using the non-parametric
Spearman's correlation coefficients within each of the
four race and sex groups. Multivariate linear regres-
sion was used to explore the independent correlates of
serum Lp(a) in Blacks and in Whites separately. Ex-
planatory variables were chosen on the basis of
previously demonstrated associations with Lp(a) or
because of known relations with blood lipids or
lipoproteins. Because of the skewed distribution of
serum Lp(a), the natural logarithm was used when fit-
ting models.
RESULTS
Cardiovascular Risk Factors
Race- and sex-specific levels of cardiovascular risk
factors are summarized in Table 1. Details of the
cardiovascular risk factors distribution have been
published elsewhere.2328-29 According to the study
design, the four sex and race groups were similar in age
in both countries. Total cholesterol, LDL-cholesterol,
and apoB were higher in Whites compared to Blacks.
HDL-cholesterol and apoA were higher in men com-
pared to women in the Seychelles but higher in women
compared to men in Switzerland. Body mass index was
higher in women compared to men in the Seychelles
but higher in men than in women in Switzerland. Dif-
ferent proportions of smokers were found in men
(55%) and in women (11%) in the Seychelles while
more balanced proportions were found in men (36%)
and in women (25%) in Switzerland. High blood
pressure was more prevalent in men compared to
women in the two countries and more prevalent in the
Seychelles compared to Switzerland.
The unusual higher HDL-cholesterol and apoA
levels in men compared to women in the Seychelles can
mostly be accounted for by the very high consumption
of alcohol by men30and the much higher prevalence of
obesity in women than in men31 (data not shown). A
prevalence of diabetes of 7% in male and in female
Seycheiiois aged 35-6431 is comparable to the
prevalence in Switzerland. Based on clinical ex-
perience, hormonal contraception is probably not
much less frequently used in the Seychelles than in
Switzerland; almost no Seycheiiois postmenopausal
women received replacement hormonal therapy
whereas the figure is estimated to be around 10-15% in
Switzerland.
Distribution of Serum Lp(a)
Race-, sex-, and age-specific untransformed mean
values and selected percentiles of serum Lp(a) are
shown in Table 2. Sex- and age-specific median Lp(a)
concentrations were approximately twofold higher in
Blacks compared to Whites. No clear pattern between
serum Lp(a) and age was observed in Black and in
White men. In contrast, serum Lp(a) increased
TABLE 1 Mean values and proportions of some cardiovascular risk factors in Seycheiiois Blacks and Swiss Whites aged 25-64 years, Seychelles
Cardiovascular Disease Study 1989 and MONICA Vaud/hribourg 1988-1989
No.
Seycheiiois
Men
328
45.3±l l .2°
4.94±1.08
2.91 ±1.12
1.52±0.56
1.50±0.45
1.01 ±0.35
23.2±3.9O
55.3
11.1 ±7.50
136±25
89±15
33.7
Blacks
Women
371
45.5±11.6
5 35±1.2O
3.54±1.16
1.39±0.37
1.39±0.32
1.I3±O.37
26.9±6.00
11.0
6.8±6.4
I32±24
85±15
27.1
Swiss
Men
300
43.8±J 1.8
6.37±I.14
4.12±0.92
1.28±0.32
1.26±0.21
l.30±0.33
25.5±3.4O
36.3
23.8±11.5
131 ± 15
80±10
14.3
Whites
Women
334
44.5±11.8
6.28±l.36
3.87±l.O9
1.54±0.39
1.42±0.22
1.17±0.32
24.7±4.50
24.6 '
16.3±7.3O
125±18
75±9
11.1
Age (years)
Total cholesterol (mmol/1)
LDL-choleslerol (mmol/l)
HDL-cholesterol (mmol/1)
Apoprotein A-l (mg/l)
Apoprotein B (mg/l)
Body mass index (kg/m2)
Cigarette smoking Cft)
Cigarettes per day per smoker
Systolic blood pressure (mm Hg)
Diastolic blood pressure (mm Hg)
High blood pressure CM)b
' Mean ± standard deviation (details of the distribution have been published elsewhere).23-28'29
3
 Systolic/diastolic blood pressure > 160/95 mm Hg or under antihypertensive treatment.
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TABLE 2 Mean values, standard deviations, and percemites of serum
lipoprotein(a) in Seychellois Blacks and S*iss Whites by race, sex and
age, Seychelles Cardiovascular Disease Study 1989 and MONICA
Vaud/Fribourg 1988-1989
Men
25-34
35-44
45-54
55-64
Total
Women
25-34
35-44
45-54
55-64
Total
Men
25-34
35^14
45-54
55-64
Total
Women
25-34
35-44
45-54
55-64
Total
No.
67
80
93
89
329
73
97
93
109
372
78
81
65
76
300
82
85
84
83
334
Mean
272
392
332
391
350
359
261
358
463
364
261
262
298
219
259
234
241
259
261
249
SD1
274
466
467
398
414
433
277
458
630
479
487
448
529
328
541
345
308
329
306
321
10
Percentiles
25 50
Seychellois Blacks
30
39
29
32
31
37
37
51
44
42
Swiss
20
18
19
21
19
24
20
28
21
23
74
87
54
93
76
120
77
95
134
94
Whites
31
31
45
35
32
36
37
53
66
46
175
236
182
221
214
213
175
193
286
208
71
77
82
98
82
87
105
127
145
114
75
421
571
380
574
521
509
334
450
537
457
221
316
259
232
251
279
394
399
348
347
90
631
814
801
950
807
799
599
1012
1170
812
679
835
927
571
782
637
688
626
655
637
* Standard deviation.
monotonically between 25 and 64 years in White
women and a substantial increase occurred in the age
group 55-64 in Black women. Median serum Lp(a) was
weakly but significantly higher in women than in men
in Switzerland (114 versus 82 mg/1; P = 0.024) while
no difference was observed in the Seychelles (208 ver-
sus2\4 mg/1), respectively; P = 0.641). Median serum
Lp(a) was higher in Blacks than in Whites (210 versus
100 mg/1; P = < 0.001). Serum Lp(a) values cor-
responding to the upper percentiles tended to increase
with age in Blacks but not in Whites.
The distribution of serum Lp(a) was highly posi-
tively skewed in the two populations (skewness in
Blacks/Whites: 3.42/3.47) (Figure 1) and could be
fairly well normalized through a natural logarithm
transformation (resulting skewness in Black/Whites:
-0.02/0.04). Serum Lp(a) mean values calculated from
the loge scale were 184 ± 3.3/198 ± 3.2 mg/1 in
male/female Seychellois and 94 ± 1.6/119 ± 3.5 mg/1
in male/female Swiss.
Figure 2 indicates the proportions of individuals
with serum Lp(a) above selected threshold values in the
range, 100-1000 mg/1. Blacks had an approximately
50% greater risk than Whites of having serum Lp(a)
above the selected thresholds (e.g. risk ratio for Lp(a)
>300 mg/1: 1.56; 95% confidence interval [CI] :
1.26-1.75).
We also performed multiple logistic regression to
investigate the association between ethnicity and
elevated serum Lp(a) levels after adjustment for
selected variables (in this analysis serum Lp(a)
>300 mg/1 was coded as 1 and Lp(a) $300 as 0). The
odds ratio (OR) for ethnicity without adjusment (OR
= 1.78; 95% CI : 1.40-2.26) did not change after ad-
justment for sex, age, body mass index, alcohol, and
smoking habits (OR = 1.76; 95% CI : 1.39-2.23) but
substantially increased after additional adjustment for
total cholesterol (OR = 2.26; 95% CI : 1.75-2.93).
Correlates of Serum Lp(a)
Table 3 shows the Spearman's correlation coefficients
between serum Lp(a) and selected variables. Total
cholesterol and LDL-cholesterol were statistically
significant univariate correlates of serum Lp(a) in the
four race and sex groups and the magnitude of the cor-
relation coefficients were similar in Blacks compared
with Whites. ApoB correlated with serum Lp(a) in all
race and sex groups except in Black women.
Multivariate linear regression models were carried
out to identify independent predictors of serum Lp(a)
in Blacks and in Whites separately. Total cholesterol,
apoB and LDL-cholesterol may be considered as
surrogates of cholesterol-rich lipoproteins and this is
substantiated by Pearson's correlation coefficients be-
tween any combination of these three lipids ranging
between 0.80 and 0.91 in both races. Therefore,
multivariate models included either total cholesterol,
apoB or LDL-cholesterol in addition to the other in-
dependent variables. Total cholesterol, apoB, or LDL-
cholesterol were significantly associated with the
logarithm of serum Lp(a) in both Black and White
populations after adjustment for the other variables
(Table 4). The magnitude of the partial regression
coefficients for total cholesterol, LDL-cholesterol, and
apoB were similar in Blacks and in Whites, indicating
that the effect of these lipids on serum Lp(a) was not
modified by race. Sex was a weak but significant
multivariate correlate of serum Lp(a) in Whites
(regression coefficient = -0.29; standard error =
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FIGURE 1 Frequency distribution of serum lipoprotein(a) in Seychellois Blacks and in
Swiss Whites. Seychelles Cardiovascular Disease Study 1989 and MONICA Vaud/
Friboun 1988-1989
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FIGURE 2 Proportions (and ratios of these proportions) of Seychellois Blacks and
Swiss Whiles with serum lipoprotem(a) above selected thresholds, Seychelles Cardio-
vascular Disease Study 1989 and MONICA Vaud/Fnbourg 1988-1989
TABLE 3 Spearman's correlation coefficients between lipoprotem(a) and selected variables0 in Seychellois Blacks and Swiss Whites, Seychelles
Cardiovascular Disease Study 1989 and MONICA Vaud/Fribourg 1988-1989
Seychellois Blacks
Men
Women
Swiss Whites
Men
Women
Total C
0.15"
O . B " *
0.17**
0.20"*
LDL-C"
0.22*"
0.20***
0.21***
0.24*"
Apo B
0.11*
0.06
0.16**
0.18*"
HDL-C
-O.01
0.06
-0.07
-0.04
Apo A-l
-0.06
0.08
-O.02
-0.03
BMI
-0.01
0.01
0.03
0.08
Alcohol
-0.03
-0.04
0.03
0.01
Cigarettes
-0.01
-0.02
-0.01
-0.05
Age
0.06
0.07
0.07
0.11*
0
 Total C: total cholesterol; LDL-C: LDL-cholesterol; HDL-C: HDL-cholesterol; BMI: body mass index.
• P < 0.05; • • P < 0.01; • " P < 0.001.
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TABLE 4 Regression coefficients of lipids for the prediction of
logarithm of serum lipoprolein(a) in models including either total
cholesterol, LDL-cholesierol, or apoprotein B in addition to other in-
dependent variables,' Seychelles Cardiovascular Disease Study 1989
and MONICA Vaud/Fribourg 1988-1989
Total cholesterol (mmol/l)
LDL-cholesterol (mmol/l)
Apoprotein B (mg/l)
Seychellois
(No. =
if
0.21
0.27
0.34
Blacks
701)
SEC
0.04**
0.04"
0.14*
Swiss
(No.
If
0.19
0.30
0.60
Whites
- 634)
SEC
0.04**
0.05"
0.17"
a
 The other independent variables in all models were: age, sex, body
mass index, drinking habits, cigarette-smoking, HDL-cholesterol.
b
 Regression coefficient.
c
 Standard error.
* P < 0.01; ** P < 0.001.
0.12; P = 0.014) but not in Blacks. HDL-cholesterol,
age, body mass index, smoking, and alcohol did not
correlate with serum Lp(a) in the two populations. No
linear combination of the independent variables could
explain more than 5.3% of the variance of the natural
logarithm of serum Lp(a). The variance explained by
all variables other than lipids (e.g. age, sex, body mass
index, smoking, and alcohol) was smaller than 1% in
the two populations.
DISCUSSION
Distribution of serum Lp(a) was highly asymmetrical
in both Seychellois Black and Swiss White popula-
tions. The similar computed values of skewness in both
populations and the fairly constant ratio of the pro-
portions of Black and Whites with serum Lp(a) above
a wide range of threshold values indicated that the
distribution of serum Lp(a) was similarly skewed in
Blacks and in Whites but that serum Lp(a) concentra-
tions were shifted to higher values in Blacks. The
distribution of serum Lp(a) in Black Seychellois dif-
fered substantially from the nearly Gaussian distribu-
tion of serum Lp(a) reported in small groups of Black
Sudanese and Congolese219-20 but it was consistent
with the distribution of serum Lp(a) found in a large
population-based study of Black American children
and adolescents.M The approximately twofold higher
median serum Lp(a) concentrations found in
Seychellois Blacks compared to their Swiss White
counterparts are however consistent with published
data on the ethnic Black/White difference (Table 5).
When reading the Table, medians should be preferred
to means when comparing serum Lp(a) between dif-
ferent populations because of the highly skewed nature
of the distribution of serum Lp(a) and because some
laboratory methods are not sensitive to very high
values of serum Lp(a) (i.e. falsely low values of some
measurements).
Ethnic difference in the distribution of serum Lp(a)
raises public health concerns. Indeed, the risk for
coronary artery disease in white populations was
reported to be increased two to three times for serum
Lp(a) >300 mg/l,"1 3although serum Lp(a) might not
be such a strong risk factor for coronary artery disease
in Blacks based on the limited data available to
date.14"16 The finding, in our data, that serum Lp(a)
values corresponding to the upper percentiles tended
to increase with age in Blacks but not in Whites may be
related to increased premature deaths in Whites but
not in Blacks with high serum Lp(a), which may in-
directly support the view that serum Lp(a) is a stronger
risk factor in Whites than in Blacks. In our data, ap-
proximately 50% more Blacks than Whites had serum
Lp(a) above threshold values in the range 100-1000
mg/l (e.g. proportions of Blacks versus Whites with
serum Lp(a) >300 mg/l: 38% versus 24%).
Moreover, the odds of having elevated serum Lp(a) in
Blacks compared to Whites were further increased
when analytical adjustment for equal levels of serum
cholesterol was performed. From another standpoint,
it has been stated from studies in Caucasian popula-
tions that the risk associated with elevated serum Lp(a)
was dependent upon jointly elevated serum LDL-
cholesterol."-32 In this view, serum Lp(a) would be a
weaker cardiovascular risk factor in the Seychelles
considering that serum LDL-cholesterol was notably
lower in the Seychelles than in Switzerland. Since
serum Lp(a) may substantially differ in molecular
structure across populations,20 further epidemiological
studies will have to consider the possibility that the
pathogenic action of Lp(a) might differ depending
upon the Lp(a) species and establish the relative pro-
atherogenic and prothrombotic roles of all Lp(a)
species and their affiliated apo(a).
The correlates of serum Lp(a) in this study were
similar in Blacks and in Whites and were generally con-
sistent with those identified in other reports. Serum
Lp(a) did not vary substantially with age in Black and
in White men but increased serum Lp(a) levels were
found in the older Black and White women. These
findings are consistent with other reports in which
serum Lp(a) concentration did not vary substantially
with age33 but was increased in postmenopausal
women presumably due to the decrease in oestrogen
levels.734-35 Total cholesterol, LDL-cholesterol and
apoB were significant univariate and multivariate cor-
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TABLE 5 Ethnic (Black/While) difference in serum lipoprotein(a) in selected studies
Type of populalion
Country
Ref. Type of
assay*
Subjects
(No.)
Mean Lp(a)
(mg/1)
Median Lp(a)
(mg/1)
Black While Black White Black White
General population
Seychelles/Switzerland
Children aged 8-17 years
USA
Adult volunteers/health study
Nigeria/Belgium
Employees
USA
Healthy people
Congo/France
Healthy people/population
Sudan/Iceland
— RIA
14 ELISA
21 ELISA
18 EID
19 EID
20 EID
701 634 357
885 1553
60
105
81
105
60
81
297
177
134 313
239
184 457
254
172
160
170
107
135
210
252
147
208
100
94
74
70
* RIA: radioimmunoassay; EID- electroimmunodiffusion; ELISA: enzyme-linked immunosorbent assay.
relates of serum Lp(a) in both Black and White
populations. Ethnicity did not modify the relation of
these lipids to Lp(a) as suggested by the similar
magnitude of the regression coefficients found in
Blacks and in Whites. Associations relating serum
Lp(a) to LDL-cholesterol or total cholesterol have
been noticed in other studies. 7-36'37 The relation of
these lipids to serum Lp(a) may however not be causal
but rather reflect that measurements of serum total
cholesterol, LDL-cholesterol, and apoB also measure
cholesterol and apoB contained in the serum lipopro-
tein Lp(a). In our study, HDL-cholesterol, apoA,
body mass index, smoking, alcohol consumption, and
sex did not correlate with serum Lp(a) in the two
populations, in agreement with studies reporting a lack
of association between serum Lp(a) and body mass
index,38 smoking,7 and alcohol.37 It is remarkable that
any combination of the considered variables explained
only very little (<5.3%) of the variance of serum
Lp(a) in the two populations. When comparing these
two populations, White Swiss and Black Seychellois
undoubtedly differ in many respects. However no
additional environmental factors have been yet iden-
tified to correlate substantially with serum Lp(a) in
populations and the ethnic difference in serum Lp(a)
found in this study is therefore not likely to be biased
by known confounding factors. These findings are
consistent with the hypothesis that genetic factors ac-
count for most of the variation of serum Lp(a) in both
populations.
It has indeed been established that a single gene
determines a polymorphism of apo(a) which relates to
serum Lp(a) concentration.2 Heterogeneity among
populations in the distribution of alleles of the gene en-
coding apo(a) may therefore explain some of the
observed heterogeneity in serum Lp(a) among various
ethnic groups. Interestingly, variability in apo(a) size
polymorphisms explained only little of the variation in
serum Lp(a) in Blacks compared to other populations
(0.19 in Black Sudanese but 0.41 in Tyroleans and 0.77
in Malays).20 Recent investigations at the apo(a) gene
level did, however, demonstrate in Whites that the
inter-individual variability in serum Lp(a) could be ex-
plained almost entirely by variation at the apo(a) locus
while only a fraction was explained by the apo(a) size
polymorphism.439 Conducting similar investigations in
other ethnic groups may further strengthen the
hypothesis that most of the variation of serum Lp(a) is
under genetic control in all populations and help
elucidate racial differences in serum Lp(a) levels.
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